Cranewood Financial Corporation

All filings by Cranewood Financial Corporation on record concern Eastwood Bio-Medical Canada Inc. In total, 4 filings cover trades dated from 26 June 2026 to 28 July 2026.

On the open market, the record shows 3 purchases worth €2,730 and 1 sale worth €1,835. The net balance comes to €896 on the buying side. Unlike grants, an open-market purchase is paid for by the insider, at the market price.

The median purchase comes to €611. Relative to company size, the median is 0.0008% of market cap (3 purchases with a known value). None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.

On 30 July 2026 came the latest disclosure, an open-market purchase for €610 in Eastwood Bio-Medical Canada Inc. Between a trade and the moment it shows up on SEDI, the median delay is 3 days. That lag is the time during which only the insider knows about the trade. This summary is built from SEDI disclosures alone and does not predict where the share price will go.